MREO Mereo BioPharma Group plc

NEUTRAL Impact: 4/10 Institutional Cluster
Horizon weeks Processed 3d 21h ago
Institutional cluster: 4 buyers, 1 sellers (bullish)

Executive Summary

Institutional cluster shows net accumulation in MREO during 2025-Q3, with 4 buyers adding $10.4M and 1 seller reducing $2.8M. Buyers are predominantly mega-passive funds (State Street, Morgan Stanley, UBS) and hedge fund Citadel, all doubling positions. The sole seller is quant fund RenTech trimming 60%. Given the small market cap ($47M), the net buying of $7.6M is material but the passive nature of most buyers weakens the conviction signal.

Key Financial Metrics

Direction
accumulating
Buy Value
$15.7M
Sell Value
$4.0M
Net Flow
$7.6M

Institutional Positions

Net institutional flow: $7.6M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
State Street DOUBLED +195.3% $273.0K $152.0K
Morgan Stanley DOUBLED +326.1% $6.9M $4.8M
Citadel DOUBLED +317% $6.5M $4.5M
UBS DOUBLED +159.9% $2.0M $987.0K

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
RenTech TRIM -60.1% $4.0M -$2.8M

Actionable Insight

The cluster is dominated by passive fund doubling, which may reflect index rebalancing rather than a strong conviction bet. However, Citadel's active doubling adds a proprietary signal. Monitor for upcoming pipeline catalysts (e.g., alvelestat data) that could validate the accumulation. The 45-day 13F reporting lag means positions may have been adjusted since quarter-end.

Key Facts

  • 4 institutional buyers (State Street, Morgan Stanley, Citadel, UBS) each doubled their positions
  • Aggregate buying value: $15.7M; aggregate selling value: $1.2M
  • Net institutional inflow: approx. $7.6M, representing ~16% of market cap
  • Only RenTech reduced holdings, trimming 60.1% of its position

Financial Impact

Net institutional buying of approximately $7.6M, with total buyer holdings of $15.7M vs. seller holdings of $1.2M

institutional ownershipfloat

Risk Factors

  • Small-cap biotech volatility with binary pipeline risk
  • 13F reporting lag: positions may already be unwound
  • Passive fund flows may not reflect fundamental thesis

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
71% bullish (14 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-MREO-2025-Q3
3 reports for MREO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MREO — sortable, filterable
Type Now
Jun 11, 2026
3d ago
Institutional Cluster
NEUTRAL ★ 4/10
$0.3024 awaiting T+5awaiting T+5
May 12, 2026
4w ago
Press Release
BEARISH ★ 6/10
$0.2460 $0.2370▲ +3.66%▲ +3.74%
Mar 19, 2026
12w ago
Press Release
MIXED ★ 6/10
$0.3610 $0.3390▼ −6.09%▼ −3.88%
Showing 3 of 3

US Market Status

Market Closed — Opens in 2h 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access